اختبار توزيع بولي-أ لـ SaRNA

• التطورات في اختبار توزيع بولي-أ saRNA

  فضلاً عن ذلك فإن هذا النهج يوفر توجيهاً لتطوير أدوية جديدة وأكثر فعالية ـ أدوية قد تكون أكثر أماناً وقوة. على سبيل المثال، فإن الدواء الذي يعمل على نوع واحد فقط من الخلايا لن يقتل بعض خلايا الجسم عن طريق الخطأ. وهو عامل مهم لأنه يساهم جزئياً في سلامة المريض من خلال عدم الإضرار به مع الرعاية.

• اختبار توزيع بولي-أ SaRNA للعلاجات المستهدفة

  قد يستفيد تحرير الجينات وما شابه ذلك أيضًا من الاختبار إنترلوكين سيرك آر إن إيه توزيع البولي أ. يتيح تحرير الجينات للعلماء تغيير الحمض النووي داخل جسم الشخص. القدرة على إصلاح الاضطرابات الجينية وربما حتى منعها من الإصابة بأمراض أيضًا. CRISPR-Cas9 - إحدى التقنيات التي يستخدمها العلماء لتحرير الجينات وهي وسيلة لإجراء تعديلات محددة.

• تحرير الجينات بطريقة أكثر أمانًا وفعالية باستخدام اختبار توزيع poly-A saRNA

  However, from the researchers' perspective, تصنيع البلازميد AAV Manufacturing can bring about at least some unintended off-target effects. Testing like that, the researchers said, will help them get a handle on what to expect when applying the CRISPR-Cas9 system — meant for gene editing —to RNA processing. Because RNA processing has an effect on gene expression, it's a smoother and more effective method to edit the gene.

لماذا تختار Yaohai SaRNA poly-A Distribution Testing؟

• التخصيص والكفاءة وفعالية التكلفة

  Yaohai Bio-Pharma has experience in manufacturing biologics that are created from microorganisms. We offer bespoke RD solutions as well as manufacturing services while minimising potential risks. We have worked with diverse techniques, such as recombinant cellular subunits, vaccines (including peptides), growth factors, hormones, and the SaRNA poly-A Distribution Testing. We are a specialist in many microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) and bacteria intracellular soluble, and inclusion body (yields up to 10g/L). We have also developed a BSL-2 fermentation platform to create bacterial vaccines. We have a track record of improving production processes, thereby increasing yields and reducing costs. We have a highly-efficient technology team to ensure timely and high-quality delivery of projects. This helps us bring your products that are unique faster to the market.

• الخبرة المهنية والخبرة الواسعة

  Yaohai Bio-Pharma is a leading microbial biologics CDMO. Our main focus has been the production of SaRNA poly-A Distribution Testing and therapeutics to treat pets, human and veterinary health. We have state-of-the-art RD platforms and manufacturing technology that cover the entire manufacturing process beginning with the development of microbial strains Cell banking, process and method development, through commercial and clinical manufacture that ensures the successful delivery of innovative solutions. Over time we've gained a vast knowledge of microbial-based bio processing. We have successfully completed more than 200 global projects, and help our clients with navigating the rules and regulations of the US FDA, EU EMA, Australia TGA, and China NMPA. We are able to react promptly to market demands and provide tailored CDMO services due to our experience and expertise.

• سلسلة توريد قوية وقدرات تصنيعية

  Yaohai Bio-Pharma, a top 10 producer of SaRNA poly-A Distribution Testing, specializes in microbial fermentation. We have set up a modern facility with advanced facilities as well as robust RD manufacturing capabilities. Five production lines for drug substances complying with GMP standards for microbial purification and ferment along with two automated fill and finish lines for vials as well as cartridges as well as pre-filled needles are readily available. The available fermentation scales range between 100L and 2000L. Vial filling specifications cover 1ml - 25ml. the pre-filled cartridge or syringe filling specifications are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. Our plant produces big molecules that are exported to all over the world.

• نظام الجودة والامتثال التنظيمي العالمي

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates SaRNA poly-A Distribution Testing as well as regulatory affairs. We have a quality management system which is in line with current GMP standards as well as global regulations. Our team of regulatory experts is proficient in global regulatory frameworks to accelerate biological launches. We ensure traceable production processes quality products, as well as complying with the rules of the US FDA and EU EMA. Australia TGA and China NMPA are also satisfied. Yaohai BioPharma has successfully passed the audit on site of the European Union's Qualified Person (QP) for our GMP quality system as well as our production facility. Furthermore, we have cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

فئات المنتجات ذات الصلة

• الطرق التحليلية للحمض النووي البلازميد
• تصنيع البكتيريا AP205 VLP
• تصنيع البكتيريا Q VLP
• تصنيع لقاح VLP الكيميري
• تصنيع اللقاحات المترافقة VLP
• تصنيع لقاح الحمض النووي
• تخمير الإشريكية القولونية لإنتاج VLP
• تصنيع ناهض GLP-1
• التصنيع التناظري GLP-1

لم تجد ما تبحث عنه؟
اتصل بمستشارينا لمزيد من المنتجات المتاحة.